Emerging Treatments and Technologies

An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Glibenclamide as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on Metformin

  1. Anthony H. Barnett, BSC, MD, FRCP1,
  2. Manfred Dreyer, MD2,
  3. Peter Lange, MD3,
  4. Marjana Serdarevic-Pehar, MD4 and
  5. on behalf of the Exubera Phase III Study Group
  1. 1University of Birmingham and Heart of England National Health Service Foundation Trust (Teaching), Birmingham, U.K.
  2. 2Department of Diabetes and Metabolism, Bethanien Krankenhaus, Hamburg, Germany
  3. 3Department of Respiratory Medicine, Hvidovre University Hospital, Hvidovre, Denmark
  4. 4Pfizer, Sandwich, U.K.
  1. Address correspondence and reprint requests to A.H. Barnett, Undergraduate Centre, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, B9 5SS, U.K. E-mail: anthony.barnett{at}heartofengland.nhs.uk
Diabetes Care 2006 Aug; 29(8): 1818-1825. https://doi.org/10.2337/dc05-1880

Article Information

vol. 29 no. 8 1818-1825
DOI 
https://doi.org/10.2337/dc05-1880
PubMed 
16873786
Published By 
American Diabetes Association
Print ISSN 
0149-5992
Online ISSN 
1935-5548
History 
  • May 18, 2006
  • October 4, 2005
  • Published in print July 27, 2006.
Copyright & Usage 
DIABETES CARE

Author Information

  1. Anthony H. Barnett, BSC, MD, FRCP1,
  2. Manfred Dreyer, MD2,
  3. Peter Lange, MD3,
  4. Marjana Serdarevic-Pehar, MD4 and
  5. on behalf of the Exubera Phase III Study Group
  1. 1University of Birmingham and Heart of England National Health Service Foundation Trust (Teaching), Birmingham, U.K.
  2. 2Department of Diabetes and Metabolism, Bethanien Krankenhaus, Hamburg, Germany
  3. 3Department of Respiratory Medicine, Hvidovre University Hospital, Hvidovre, Denmark
  4. 4Pfizer, Sandwich, U.K.
  1. Address correspondence and reprint requests to A.H. Barnett, Undergraduate Centre, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, B9 5SS, U.K. E-mail: anthony.barnett{at}heartofengland.nhs.uk
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: July 2006 to January 2021

Rendering graph...
AbstractFullPdf
Jul 20061241972
Aug 2006387133346
Sep 200610771120
Oct 200612891115
Nov 20068116879
Dec 20065115228
Jan 20079326664
Feb 200786165171
Mar 200764161135
Apr 20074510093
May 20076711384
Jun 2007708789
Jul 2007366466
Aug 2007316666
Sep 2007498067
Oct 2007488367
Nov 2007564335
Dec 2007172515
Jan 2008263825
Feb 2008372323
Mar 2008462825
Apr 2008412810
May 2008502727
Jun 2008473521
Jul 2008483120
Aug 2008491816
Sep 2008773424
Oct 2008603011
Nov 2008502625
Dec 2008452031
Jan 2009381625
Feb 2009412321
Mar 2009542926
Apr 2009481420
May 2009261921
Jun 200967812
Jul 200975615
Aug 200958915
Sep 2009831111
Oct 2009781215
Nov 2009781920
Dec 200987917
Jan 201079816
Feb 201075718
Mar 2010851618
Apr 2010761020
May 2010691719
Jun 201064258
Jul 2010631312
Aug 2010571318
Sep 2010862212
Oct 2010353116
Nov 201061299
Dec 2010372114
Jan 2011422816
Feb 2011382410
Mar 2011693020
Apr 2011632741
May 2011513319
Jun 2011442221
Jul 2011461926
Aug 2011553620
Sep 2011703814
Oct 2011563418
Nov 2011712613
Dec 2011652611
Jan 201267288
Feb 201252218
Mar 201267297
Apr 2012512513
May 2012482512
Jun 201251811
Jul 2012582216
Aug 2012441619
Sep 201258159
Oct 2012471519
Nov 2012533121
Dec 201242259
Jan 201348239
Feb 201343329
Mar 201346208
Apr 201338407
May 2013442012
Jun 20133259
Jul 201333146
Aug 20133664
Sep 20132672
Oct 20133755
Nov 201330142
Dec 20133669
Jan 201444323
Feb 201440268
Mar 201441298
Apr 201446337
May 2014443012
Jun 2014242711
Jul 201438417
Aug 2014352510
Sep 201422166
Oct 201421164
Nov 2014361719
Dec 20147116
Jan 201520233
Feb 201520186
Mar 201544238
Apr 201531266
May 201518195
Jun 2015211419
Jul 201524276
Aug 201519227
Sep 201514177
Oct 201535267
Nov 201522219
Dec 201531176
Jan 2016392113
Feb 201622143
Mar 2016643914
Apr 2016281213
May 2016114617
Jun 20164256
Jul 2016478
Aug 201622618
Sep 20162227
Oct 2016142613
Nov 20163155
Dec 20162157
Jan 201711411
Feb 20173185
Mar 20175141
Apr 20173171
May 20177189
Jun 2017474
Jul 2017271
Aug 201722213
Sep 20175154
Oct 20177123
Nov 20174232
Dec 20172186
Jan 20186184
Feb 201831911
Mar 20183112
Apr 201832510
May 201833116
Jun 20185386
Jul 20182154
Aug 20181183
Sep 20180177
Oct 201812211
Nov 201822511
Dec 20186285
Jan 201911333
Feb 20190368
Mar 20195366
Apr 201923113
May 201975917
Jun 201913413
Jul 201934516
Aug 201943612
Sep 20193465
Oct 2019611316
Nov 20192426
Dec 20190344
Jan 20206445
Feb 20201325
Mar 20201414
Apr 202052610
May 20200197
Jun 20201106
Jul 202001688
Aug 20201116
Sep 202023525
Oct 20203279
Nov 20200306
Dec 20203177
Jan 202131411

Back to top
Diabetes Care: 29 (8)

In this Issue

August 2006, 29(8)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Email Article
Citation Tools
Add to Selected Citations

An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Glibenclamide as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on Metformin
Anthony H. Barnett, Manfred Dreyer, Peter Lange, Marjana Serdarevic-Pehar
Diabetes Care Aug 2006, 29 (8) 1818-1825; DOI: 10.2337/dc05-1880
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section